angiostatin gene-expressing Semliki Forest Virus vector (Regulon)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameangiostatin gene-expressing Semliki Forest Virus vector (Regulon)
Drug Alias NameLipoVang
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegulon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegulonF. Hoffmann-La Roche Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A